Brief: Clearside Biomedical Announces Completion Of Final Participant Visit In Odyssey Phase 2B Trial Of CLS-AX
27/08/2024 12:08
Aug 27 (Reuters) - Clearside Biomedical Inc CLSD.O :
* CLEARSIDE BIOMEDICAL ANNOUNCES COMPLETION OF FINAL
PARTICIPANT
VISIT IN ODYSSEY PHASE 2B TRIAL OF CLS-AX IN WET AMD
* CLEARSIDE BIOMEDICAL INC - TOPLINE DATA EXPECTED TO BE
REPORTED
DURING WEEK OF OCTOBER 7, 2024
Source text for Eikon: ID:nGNX48DqPR
Further company coverage: CLSD.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Clearside Biomedical,
See all newsBrief: Clearside Biomedical Completes Financial Restructuring And Emerges From Chapter 11 With Steel Partners As Plan Sponsor
U.S. STOCKS ON THE MOVE-Merck, Genco, Tesla
U.S. STOCKS ON THE MOVE-Morgan Stanley, Merck, Genco
Clearside Biomedical plunges after filing for Chapter 11 bankruptcy
U.S. STOCKS ON THE MOVE-Bristol Myers Squibb, Palo Alto Networks, MP Materials